Quick Answer
USANA HEALTH SCIENCES INC reported Stockholders Equity of $533.10 million for the year ending 2025.
- USANA HEALTH SCIENCES INC showed an increase of +0.2% in Stockholders Equity from 2024 to 2025.
- This data is from USANA HEALTH SCIENCES INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $187.65 million | Q2 2013: $214.01 million | Q3 2013: $238.65 million | Q1 2014: $279.74 million | Q2 2014: $254.25 million | Q3 2014: $199.45 million | Q1 2015: $253.31 million | Q2 2015: $284.52 million | Q3 2015: $313.39 million | Q1 2016: $244.91 million | Q2 2016: $273.93 million | Q3 2016: $307.71 million | Q1 2017: $353.93 million | Q2 2017: $383.14 million | Q3 2017: $362.81 million | Q1 2018: $400.98 million | Q2 2018: $429.28 million | Q3 2018: $435.59 million | Q1 2019: $391.22 million | Q2 2019: $384.16 million | Q3 2019: $314.29 million | Q1 2020: $317.61 million | Q2 2020: $349.08 million | Q3 2020: $389.12 million | Q1 2021: $402.78 million | Q2 2021: $418.62 million | Q3 2021: $399.08 million | Q1 2022: $389.95 million | Q2 2022: $403.68 million | Q3 2022: $411.10 million | Q1 2023: $455.35 million | Q2 2023: $468.82 million | Q3 2023: $470.39 million | Q1 2024: $499.99 million | Q2 2024: $512.21 million | Q3 2024: $533.09 million | Q1 2025: $529.76 million | Q2 2025: $531.06 million | Q3 2025: $528.07 million.
- Over the full 15 years of available data (2011 to 2025), USANA HEALTH SCIENCES INC's Stockholders Equity has grown by 206.5%.
- Historical annual values: Fiscal year 2025: $533.10 million | Fiscal year 2024: $532.11 million | Fiscal year 2023: $497.20 million | Fiscal year 2022: $434.47 million | Fiscal year 2021: $395.12 million | Fiscal year 2020: $441.65 million | Fiscal year 2019: $351.71 million | Fiscal year 2018: $391.15 million | Fiscal year 2017: $363.21 million | Fiscal year 2016: $325.29 million | Fiscal year 2015: $280.85 million | Fiscal year 2014: $230.16 million | Fiscal year 2013: $260.52 million | Fiscal year 2012: $185.57 million | Fiscal year 2011: $173.91 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: